Dosing Protocol
Typical Dose 1.6 mg
Range 1.6 - 6.4 mg
Maintenance 1.6 mg 2x weekly
Pharmacokinetics
Half-Life 2.0 hrs
Onset 30 min
Peak 1.5 hrs
Duration 6.0 hrs
Bioavailability 85%
Primary Route Subcutaneous
Administration
Routes Subcutaneous
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 27-29G
Syringe Type Insulin
Timing Morning
Reconstitution
Diluent Sterile Water
Volume 1 mL
Stability 14 days refrigerated
Vial Sizes 1.6, 3.2 mg
Special Instructions
Well-established safety in clinical use. Approved in 35+ countries for hepatitis and cancer adjuvant therapy.